A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis (DCM ) Treated With Olorofim Plus Baseline SOC or Placebo Plus Baseline SOC

Clinical trial NCT07712484 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07712484
Sponsor: F2G Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Coccidioidomycosis Disseminated Fungal Infection Coccidioides Infection Coccidioides Immitis Infection Coccidioides Posadasii Infection Coccidioidomycosis Infection San Joaquin Valley Fever Valley Fever

Start date: 2026-12-01
Primary completion: 2028-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.